Highlights
- 1
Publications
11 publications
Funding
1 grant
Active
1 grant- MPIKL2TR002385-06Clinical and Translational Science Center - KL2National Center for Advancing Translational Sciences · 2022–2027
News mentions
2 mentionsView all WCM news ↗
- Reverse Engineering Ketamine’s Effects May Lead to New AntidepressantsMay 1, 2026
Weill Cornell Medicine investigators have “reverse engineered” ketamine’s antidepressant effects to identify potential new strategies for treating depression.
External relationships
Other
Guidepoint Global LLC